Ultima Genomics Adds Former Thermo Fisher Exec Mark Stevenson to Board of Directors
May 2, 2024
Mark Stevenson, with more than 30 years of experience in the life sciences sector, formerly Executive Vice President and Chief Operating Officer of Thermo Fisher Scientific joins Ultima Genomics’ Board of Directors FREMONT, Calif. -- Ultima Genomics, a developer of an innovative new ultra-high throughput sequencing architecture, today announced that Mark Stevenson will join its [...]
May 2, 2024
Ready-to-use kit expands range of bioanalysis kits, and enables generic detection of immune complexes in rodent samples Uppsala, Sweden: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and a leading provider of peptide synthesizers and reagents, today announced the introduction of Gyrolab® Generic Rodent Anti-Drug Antibody (ADA) Kit Reagents for the detection of circulating immune [...]
May 2, 2024
KR-HT5 is based on Akoya’s PhenoImager® HT Platform MARLBOROUGH, Mass. and SHANGHAI, China -- Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company®, and Shanghai KR Pharmtech, a leading company providing molecular diagnostic solutions in China, have jointly announced that KR-HT5, which Akoya Biosciences co-developed with Shanghai KR Pharmtech utilizing the PhenoImager HT technology as [...]
Nuclera eProtein Discovery system installed at leading academic institutes
May 2, 2024
11 installs successfully completed Novel platform automates and accelerates protein production, enabling scale-up to mg amount in less than 48 hours List of institutes includes, University College London, University of Cambridge, University of Southampton, University of Manchester, The Flanders Institute for Biotechnology (VIB) in Belgium, and the CRUK Cambridge Institute Cambridge, UK: Nuclera, the biotechnology company [...]
Bruker Completes Acquisition of Molecular Diagnostics Innovator ELITech
May 2, 2024
ELITech is a differentiated, fast growing and profitable provider of systems and assays for molecular diagnostics (MDx), biomedical systems/specialty IVD, and microbiology ELITech offers the proprietary, fully automated sample-to-answer (S2A) systems InGenius® and BeGenius® for molecular testing in mid-sized hospitals Diversified ELITech MDx assay portfolio focused on esoteric infectious disease testing ELITech has its R&D, [...]
May 2, 2024
Up to $2.5 million in funding from NIH will be used to develop TIMING™ kits for manufacturing analytics that provide end-users with rapid, specific and predictive results to accelerate translational research and the development and manufacture of more effective cell therapies to benefit patients PRESS RELEASE HOUSTON, Texas — CellChorus®, the dynamic single-cell analysis company™, [...]
Spinlock NMR Welcomes SARTOROM as Exclusive Distributor for Romania
May 2, 2024
Spinlock NMR, a pioneering leader in advanced Nuclear Magnetic Resonance (NMR) technology, is thrilled to announce the appointment of SARTOROM as its exclusive distributor for the entire territory of Romania. This strategic partnership aims to enhance accessibility to Spinlock NMR’s cutting-edge solutions throughout the Romanian industrial and scientific communities. With a shared commitment to innovation and excellence, Spinlock NMR [...]
Genomenon Partners with Pharming to Advance APDS Diagnosis
May 2, 2024
Genomenon Making Variant Data on the PIK3CD and PIK3R1 Genes Available to Genetic Testing Labs Across the World Genomenon, a genomic intelligence company, has partnered with Pharming Group in an effort to make variant data on the PIK3CD and PIK3R1 genes available to genetic testing labs, as well as clinicians and researchers, worldwide. This data [...]
$27 million to map 50 million human cellsand uncover genetic fingerprints of disease
May 1, 2024
With researchers, The Hon. David Harris MP, NSW Minister for Medical Research, and Madeleine Jandura who was diagnosed with ulcerative colitis at age 11. Illumina, a global genomics and human health company, has partnered with the Garvan Institute of Medical Research’s TenK10K project to help transform the treatment of complex diseases, starting with autoimmune diseases, [...]
May 1, 2024
Powered by pioneering technology licensed from Johns Hopkins University, the NOMADX platform aims to enable anyone to perform the rapid and accurate identification of harmful bacteria and viruses in food, water, air, and clinical applications with sensitivity equivalent to PCR NEW YORK -- NOMADX Holdings LLC ("NOMADX Holdings"), a private company pioneering new technologies for [...]

